Review
[Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin]
[Article in
Japanese]
- PMID: 7807686
Item in Clipboard
Review
[Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin]
[Article in
Japanese]
Jpn J Antibiot.
1994 Oct.
No abstract available
Similar articles
-
Sparfloxacin and levofloxacin.Med Lett Drugs Ther. 1997 Apr 25;39(999):41-3. Med Lett Drugs Ther. 1997. PMID: 9137295 No abstract available.
-
[Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].Pneumologie. 1997 Sep;51(9 Suppl):1-4. Pneumologie. 1997. PMID: 9417540 German. No abstract available.
-
Prulifloxacin. NAD-441A, NM 441, Quisnon.Drugs R D. 2002;3(6):426-30. doi: 10.2165/00126839-200203060-00013. Drugs R D. 2002. PMID: 12516950 No abstract available.
-
Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.Drugs. 1997 Apr;53(4):700-25. doi: 10.2165/00003495-199753040-00010. Drugs. 1997. PMID: 9098667 Review.
-
Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?J Antimicrob Chemother. 1997 Dec;40 Suppl A:99-101. doi: 10.1093/jac/40.suppl_1.99. J Antimicrob Chemother. 1997. PMID: 9484879 Review. No abstract available.